NeuBase Therapeutics, Inc. received notice that Franklyn G. Prendergast, M.D., Ph.D., who served as a member of the Company?s Board of Directors since July 2019, passed away. Dr. Prendergast was also a member of the Audit Committee and Compensation Committee of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 USD | -3.97% | -7.41% | -49.33% |
03-26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
03-26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
1st Jan change | Capi. | |
---|---|---|
-49.33% | 1.46M | |
+18.10% | 47.02B | |
+48.77% | 41.86B | |
+0.77% | 41.76B | |
-4.27% | 28.8B | |
+11.80% | 26.05B | |
-21.58% | 19.15B | |
+4.02% | 12.55B | |
+28.68% | 12.34B | |
-4.51% | 11.82B |
- Stock Market
- Equities
- NBSE Stock
- News NeuBase Therapeutics, Inc.
- Neubase Therapeutics, Inc. Announces Franklyn G. Prendergast Board of Directors Passed Away